Cargando…
Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050363/ https://www.ncbi.nlm.nih.gov/pubmed/24959421 http://dx.doi.org/10.3389/fonc.2014.00142 |
| _version_ | 1782319944169422848 |
|---|---|
| author | Renovanz, Mirjam Kim, Ella L. |
| author_facet | Renovanz, Mirjam Kim, Ella L. |
| author_sort | Renovanz, Mirjam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4050363 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40503632014-06-23 Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment Renovanz, Mirjam Kim, Ella L. Front Oncol Oncology Frontiers Media S.A. 2014-06-10 /pmc/articles/PMC4050363/ /pubmed/24959421 http://dx.doi.org/10.3389/fonc.2014.00142 Text en Copyright © 2014 Renovanz and Kim. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Renovanz, Mirjam Kim, Ella L. Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment |
| title | Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment |
| title_full | Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment |
| title_fullStr | Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment |
| title_full_unstemmed | Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment |
| title_short | Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment |
| title_sort | intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050363/ https://www.ncbi.nlm.nih.gov/pubmed/24959421 http://dx.doi.org/10.3389/fonc.2014.00142 |
| work_keys_str_mv | AT renovanzmirjam intratumoralheterogeneityitscontributiontotherapyresistanceandmethodologicalcaveatstoassessment AT kimellal intratumoralheterogeneityitscontributiontotherapyresistanceandmethodologicalcaveatstoassessment |